The HDL hypothesis: do recent trials with niacin add anything?
A position statement from HDL Forum Editor, Professor Philip Barter
Following the HPS2-THRIVE announcement there has been much speculation about niacin and HDL. Now it is time to bring some balance to the debate.
According to Professor John Chapman, Past-President of the European Atherosclerosis Society, INSERM, Hôpital de la Pitié, Paris, France:
'First and foremost we must not forget that in addition to raising HDL cholesterol, niacin also lowers atherogenic lipoproteins, including LDL cholesterol, triglycerides and lipoprotein(a). Clearly, HPS2-THRIVE is NOT a test of the HDL hypothesis.'Read the full report here
16-18 May, 2013: Heart Foundation Conference 2013
17-19 May , 2013: 8th Metabolic Syndrome, type II Diabetes and Atherosclerosis Congress
May 30 - June 2, 2013: NLA Scientific Sessions
2-5 June, 2013: 81st Congress of the European Atherosclerosis Society